The Welsh Government has provided £5m (around 7m USD) towards the new 700,000 sq ft facility. This support follows a £10m (14m USD) investment in the Northern Gateway in March to unlock the site’s development potential.
The construction is expected to begin early next year and once complete, will create 229 new jobs. It’ll be the first, in more than 15 years in the UK, integrated tissue production and conversion facility. It’s considered by the Italian company ICT a state-of-the-art project, and the company has already assigned a preliminary contract for a 50-acre site.
The new facility, equipped with the latest technology, will deliver consumer tissue products marketed through private retailer labels and ICT’s own brand FOXY to the UK and Irish markets.
According to the company, the location and development present the “perfect opportunity” for retailers and their customers to benefit from the highest quality tissue products with availability assured from ICT’s industry-leading supply chain expertise.
The company said they’re working with the Welsh Government team over the last two years, and it has been a very positive experience of cooperation. ICT has carried out an extensive feasibility study of potential sites all over the UK during the last three years, and they’re more than pleased with the final choice to make Deeside the new home and expand their business footprint to North Wales and the UK.
“We look forward to swiftly getting to work on the site and creating our local ICTUK team.” – said the spokesperson from ICT.